ROGAINE EXTRA STRENGTH (FOR MEN) Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Rogaine Extra Strength (for Men), and what generic alternatives are available?
Rogaine Extra Strength (for Men) is a drug marketed by Johnson And Johnson and is included in one NDA.
The generic ingredient in ROGAINE EXTRA STRENGTH (FOR MEN) is minoxidil. There are eight drug master file entries for this compound. Ninety-five suppliers are listed for this compound. Additional details are available on the minoxidil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Rogaine Extra Strength (for Men)
A generic version of ROGAINE EXTRA STRENGTH (FOR MEN) was approved as minoxidil by WATSON LABS on March 3rd, 1987.
Summary for ROGAINE EXTRA STRENGTH (FOR MEN)
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 131 |
| Clinical Trials: | 6 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ROGAINE EXTRA STRENGTH (FOR MEN) at DailyMed |
-patent-expirations.png "ROGAINE EXTRA STRENGTH (FOR MEN) drug patent expirations")
Recent Clinical Trials for ROGAINE EXTRA STRENGTH (FOR MEN)
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ohio State University Comprehensive Cancer Center | Early Phase 1 |
| Loyola University | Phase 2 |
| Cures Within Reach | Phase 2 |
Pharmacology for ROGAINE EXTRA STRENGTH (FOR MEN)
| Drug Class | Arteriolar Vasodilator |
| Physiological Effect | Arteriolar Vasodilation |
Anatomical Therapeutic Chemical (ATC) Classes for ROGAINE EXTRA STRENGTH (FOR MEN)
US Patents and Regulatory Information for ROGAINE EXTRA STRENGTH (FOR MEN)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Johnson And Johnson | ROGAINE EXTRA STRENGTH (FOR MEN) | minoxidil | SOLUTION;TOPICAL | 020834-001 | Nov 14, 1997 | OTC | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
